Sandu Pharmaceuticals Ltd. benchmarking: Perfomance to industry peers

Financial

	Sandu Pharmaceutical	Guj. Terce Lab	Omkar Pharmachem
Operational Metrics
Financials
5 yr Average ROE	3.72 %	2.73 %	2.2 %
5yr average Equity Multiplier	1.33	3.3	1.05
5yr Average Asset Turnover Ratio	1.23	1.76	0.05
5yr Avg Net Profit Margin	2.27 %	-2.57 %	44.95 %
Price to Book	0.79	3.96	3.15
P/E	21.45	0.0	350.0
5yr Avg Cash Conversion Cycle	48.49 Days	-20.6 Days	49.27 Days
Inventory Days	74.6 Days	40.01 Days	0.0
Days Receivable	26.14 Days	39.02 Days	49.27 Days
Days Payable	72.73 Days	100.7 Days	0.0
5yr Average Interest Coverage Ratio	28.2	1.07	7.4
5yr Avg ROCE	5.33 %	3.46 %	2.6 %
5yr Avg Operating Profit Margin	3.77 %	-0.49 %	44.39 %
5 yr average Debt to Equity	0.0	0.63	0.06
5yr CAGR Net Profit	0.39 %	-17.21 %	-1.89 %
5yr Average Return on Assets	2.79 %	-3.57 %	2.09 %
Shareholdings
Promoter Holding	37.79 %	40.03 %	0.03 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-12.64 %	3.81 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0